Navigation Links
Tolerx Announces Amendment to Phase 3 DEFEND Protocol
Date:8/11/2009

ent of type 1 diabetes and other autoimmune diseases. Otelixizumab targets CD3, a T lymphocyte receptor involved in normal cell signaling. Otelixizumab has not yet been approved for marketing. Data suggest that the antibody may work in patients with type 1 diabetes who have residual beta cells by blocking the function of effector T cells that mistakenly attack and destroy insulin-producing beta cells, while stimulating regulatory T cells that are understood to protect against effector T cell damage, thus preserving the beta cells' ability to make insulin.

About Tolerx

Tolerx is a biopharmaceutical company engaged in the discovery and development of novel therapies for immune-mediated diseases. The company's pipeline includes its lead candidate, otelixizumab, a targeted T cell immunomodulator partnered with GlaxoSmithKline in Phase 3 development for the treatment of type 1 diabetes; a Phase 1 candidate, MTRX1011A, an anti-CD4 antibody that is being developed in collaboration with Genentech, Inc. for the treatment of autoimmune indications; and two pre-clinical candidates, TRX518 and TRX385, that enhance immune responses and are being evaluated for potential benefit in the treatment of cancer, chronic viral diseases, and as vaccine adjuvants. Tolerx is a privately held company headquartered in Cambridge, MA USA. For more information, please visit www.tolerx.com.


'/>"/>
SOURCE Tolerx, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Tolerx Named as One of the Fierce 15 Biotech Companies of 2008
2. Laureate Announces Manufacturing Agreement with Tolerx
3. Tolerx Expands Phase 3 DEFEND Trial of Otelixizumab in Europe
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
6. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
7. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
8. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... Nov. 25 Biotech firm Replikins Lt...a from the 1918 pandemic through the prediction, o..., today issued its latest biochemical analysis of ...f the H1N1 ("Swine Flu") virus has dropped from it...t outbreak in the spring of 2009 to resting non-ep...
(Date:11/25/2009)..., ,, BOCA RATON, Fla., Nov. 25 /PRNewswire...year. Not so for BodyLogicMD. The nation,s larges... specializing exclusively in medically supervised ... physicians in its network since November 2008...to add more physician-owned centers, including one...
(Date:11/25/2009)...IJING, Nov. 25 /PRNewswire-Asia/ -- Sinovac Biotec... vaccines, announced today that it executed,a join...ian) Vaccine,Technology Co., Ltd. (Sinovac Dalian)...rcialize human-use vaccines. Sinovac will contribu...commercializing world-class vaccines; the,other pa...
(Date:11/25/2009)...ov. 25 Ardea Biosciences... D. Quart, Pharm.D., president and chief executive...nnual Health Care Conference. , ,Presentation det...alth Care Conference,Date: Tuesday, December ...: The New York Palace Hotel, New York, NY,Webcast...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...Introduction , Amplification of DNA thro... highly sensitive method capable of copying m...ngle molecule. 1 Because of the extreme sensitivi...ct from previous reactions can result in false pos...mination can be avoided by using positive , ...
...Marni Brisson, Robert Park, and Keith Hamby, , ...e, Hercules, CA 94547 , USA , ,...of fluorescence resonance energy transfer (FRET) t...ion (PCR) and melt-curve analysis is a , ...leotide polymorphisms , (SNPs). The frequ...
... and Wen Guo Jiang, Metastasis Research Group, Uni...es College of Medicine, Cardiff, UK , ,...is refers to the formation of new lymphatic vessel...eloping tissues or in tumors. In addition , ...odstream, many malignant , tumors, breast...
Other Biology Technology:Inactivation of Contaminating Templates in PCR Using High Intensity Ultraviolet Light 2Inactivation of Contaminating Templates in PCR Using High Intensity Ultraviolet Light 3Real-Time PCR/Melt-Curve Analysis: SNP Detection With FRET, Rev A 2Real-Time PCR/Melt-Curve Analysis: SNP Detection With FRET, Rev A 3Real-Time PCR/Melt-Curve Analysis: SNP Detection With FRET, Rev A 4Real-Time PCR/Melt-Curve Analysis: SNP Detection With FRET, Rev A 5Real-Time PCR/Melt-Curve Analysis: SNP Detection With FRET, Rev A 6Real-Time PCR/Melt-Curve Analysis: SNP Detection With FRET, Rev A 7Quantitation of Lymphangiogenesis Using the iCycler iQ Real-Time PCR Detection System and Scorpions Detection System, Rev A 2Quantitation of Lymphangiogenesis Using the iCycler iQ Real-Time PCR Detection System and Scorpions Detection System, Rev A 3Quantitation of Lymphangiogenesis Using the iCycler iQ Real-Time PCR Detection System and Scorpions Detection System, Rev A 4Quantitation of Lymphangiogenesis Using the iCycler iQ Real-Time PCR Detection System and Scorpions Detection System, Rev A 5
(Date:11/26/2009)... are some of the Ocean,s most distinctive resident...s strange head shape, says Michelle McComb from F... the shark,s vision. ,Perhaps their visual field h...McComb, giving the sharks excellent stereovision a... there were two schools of thought on this theory....
(Date:11/26/2009)...7 November 2009 What are the bare essentials of l...duce a cell that can survive on its own? Can we de...tand how an entire organism functions as a system?...sts in a partnership between the European Molecula..., and the Centre de Regulacio Genmica (CRG) in Bar...
(Date:11/25/2009)...firefighters, police officers and ambulance worker...ade Center complex. They battled to save people fr...ors, tackled fires and evacuated as many people as...d 17,000 people. And making their jobs even harder...d workers and their relatives jammed mobile networ...
Breaking Biology News(10 mins):Wide heads give hammerheads exceptional stereo view 2First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Magic box for mission impossible 2Magic box for mission impossible 3Snoring Isn 26apos 3Bt Sexy LLC Announces the Launch of E cards for Snorers 55585 1Snoring Isn 26apos 3Bt Sexy LLC Announces the Launch of E cards for Snorers 55585 2IBM Scientists First to Image the Anatomy of a Molecule 4913 1IBM Scientists First to Image the Anatomy of a Molecule 4913 2IBM Scientists First to Image the Anatomy of a Molecule 4913 3IBM Scientists First to Image the Anatomy of a Molecule 4913 4IBM Scientists First to Image the Anatomy of a Molecule 4913 5Hisamitsu Pharmaceutical Completes Acquisition of Noven Pharmaceuticals 55583 1Hisamitsu Pharmaceutical Completes Acquisition of Noven Pharmaceuticals 55583 2
...N (18 October 2007) -- IEEE-USA will host its firs...te.org/dcforum/ ) at the Fairview Park Marriott in...designed to promote the innovation process, highli...h professionals improve their innovation skills. ...mia and government are among those who should atte...
...bers are the champions of organ regrowth because t...estoring their organs, according to research publi...pmental Biology. The discovery that Holothuria gla...und healing and organ regeneration gives us the op... and, perhaps eventually, how to regenerate body p...
...3, Professor Laurette Dub, James McGill Chair in C...s convened an annual Health Challenge Think Tank b... health issues in a comprehensive, effective way d...ors and areas of expertise. To that end, this year...scientists, stakeholders and decision-makers, incl...
Other Biology News:First IEEE-USA Innovation Forum coming to Washington area in November 2Sea cucumbers fast track organ regrowth by healing their wounds 2Changing the global dietary environment 2
Mouse Anti-Human QARS Monoclonal Antibody, Unconjugated, Clone 5F5 from Abnova Corporation
Mouse Anti-Human QPCT Polyclonal Antibody, Unconjugated from Abnova Corporation
Mouse Anti-Human QPCT Monoclonal Antibody, Unconjugated, Clone 4E11 from Abnova Corporation
...ctional mixing devices. Stepping motors device is ...ty durable shaker to provide a uniform motion that... action scale for all modes. Microprocessor based ...nuous time, action scale and speed. The unit provi...
Biology Products: